What Is Massive Transfusion & the MTP?
Massive transfusion is defined by any one of the following — different thresholds all describe the same clinical problem, exsanguinating haemorrhage:
- Replacement of the entire blood volume within 24 hours
- >10 units of PRBC in 24 hours (≈ one adult blood volume; some texts use >20 units/24 h)
- Replacement of >50% of total blood volume within 3 hours
- >4 units of PRBC in 1 hour with ongoing bleeding (dynamic definition — catches trouble earliest)
The MTP is a pre-agreed, rehearsed hospital pathway that, on a single activation call, lets the blood bank assemble blood products in prescribed ratios and release them rapidly and repeatedly — removing ordering delays and decisions so the team can focus on stopping the bleeding. Its power is coordination, not any single number.
- Timely availability of blood & products is uncommon; delay is common — the MTP is designed to close that gap.
- It supports haemostatic resuscitation in fixed ratios — blood-based resuscitation >>> crystalloid-based resuscitation.
- Compared with unstructured ordering, a protocol improves survival, reduces total blood-product utilisation, and reduces acute infectious complications.
Components only buy time — definitive haemorrhage control (surgery, interventional radiology, endoscopy, or uterotonics/tamponade in PPH) is the treatment. Throughout, fight the self-reinforcing lethal triad — hypothermia · acidosis · coagulopathy — plus ionised hypocalcaemia (together the "diamond of death").
Deciding to Activate the MTP
Getting the timing right is the whole game, and it cuts both ways:
Impractical — wastes products and blood-bank capacity.
Increases mortality and morbidity.
The answer is a scoring trigger that predicts, early and at the bedside, which patients are likely to need massive transfusion — so you activate on physiology, before the unit count climbs. In trauma the standard tool is the ABC (Assessment of Blood Consumption) score.
Score 1 point for each of the following four bedside findings (no labs needed):
- Penetrating mechanism of injury
- SBP < 90 mmHg
- HR > 120 /min
- Positive FAST (focused assessment with sonography for trauma)
Score ≥ 2 → patient is likely to require blood transfusion → activate the MTP.
🌍 Other triggers in use
- >4 RBC units in 1 h + ongoing bleeding, or predicted need for >10 units/24 h
- Shock Index >1 (HR ÷ SBP)
- Clinical judgement: uncontrolled source + haemorrhagic shock unresponsive to the first units
🇮🇳 Indian context (NBTC / AIIMS)
- Same physiological triggers, adapted to local blood-bank stock (often whole blood, RDP, cryoprecipitate rather than SDP/fibrinogen concentrate)
- Institutional MTPs (e.g. AIIMS New Delhi) define local "pack" contents in advance with Transfusion Medicine
- Strong emphasis on early activation in obstetric haemorrhage and trauma; reserve O-negative for women of child-bearing potential
Massive Transfusion Protocol — the Sequence
This is how the protocol actually runs at the bedside once you decide to activate — from the first call, through damage control resuscitation, into repeating blood-bank packs, with a "bleeding controlled?" checkpoint after every pack that either stops the MTP or escalates to the next pack.
• Limited crystalloid · Target SBP 70–100 mmHg (permissive hypotension)
• Uncrossmatched PRBC & FFP until crossmatched blood is available
Activate & communicate
- One call to the blood bank: "Activate MTP" — state location + patient identity
- Contact the OR; send a runner to the blood bank; submit the crossmatch specimen
- Nominate a team leader and a single communicator (the only person who talks to the lab)
- Send bloods: coagulation, fibrinogen, CBC, group & crossmatch, ABG/lactate, ionised Ca²⁺ (consider TEG/ROTEM); start the rapid infuser + warmer
Damage control resuscitation (DCR)
- Limited crystalloid — do not resuscitate with litres of saline
- Target SBP 70–100 mmHg (permissive hypotension) until surgical control — but maintain perfusion in TBI
- Give uncrossmatched (emergency group O) PRBC & FFP until crossmatched blood is available — O-negative for women of child-bearing potential
Blood-bank Pack 1 + TXA
- Pack 1 = 4 PRBC : 2 FFP (RBC-predominant first pack — thawed plasma follows; move toward balanced 1:1:1 in subsequent packs)
- Tranexamic acid 1 g IV over 10 min, then 1 g over 8 h — if within 3 h of injury/onset
- Prepare the next pack in advance and repeat blood tests
Control bleeding & fight the "diamond" (in parallel)
- Definitive control: surgery / IR / endoscopy, or uterotonics + tamponade/balloon in PPH
- After each pack recheck coagulation, fibrinogen, ABG, lactate, ionised calcium & temperature
- Correct Ca²⁺ >1.1–1.15 mmol/L; keep temp >36 °C; treat acidosis by restoring perfusion
Bleeding NOT controlled → subsequent packs / targeted therapy
- Subsequent pack = 6 RBC : 6 FFP : 6 platelets (balanced 1:1:1); repeat bloods and re-check control after each — loop until bleeding is controlled
- As lab/VHA results arrive, direct components to the deficit: fibrinogen <1.5 (–2 obstetric) → cryoprecipitate/concentrate; platelets <50 (<100 if CNS/ongoing) → platelets; PT/APTT >1.5× → FFP
Bleeding controlled → deactivate & audit
- Contact the blood bank and stop the MTP promptly — avoid over-transfusion, TACO/TRALI and wastage; return unused units
- Start VTE prophylaxis once haemostasis is secure; audit every activation
Why 1:1:1?
Give red cells, plasma (FFP) and platelets in equal numbers of units — 1 : 1 : 1. The idea is to reconstitute something close to whole blood and replace all that is being lost, rather than red cells alone (which dilutes clotting factors and platelets and worsens coagulopathy).
Blood Products at a Glance
A quick reference for the components used in an MTP. For the full picture — what each contains, how it is made, storage, detailed indications and side-effects — see the dedicated topic: Blood & Blood Products →
| Product | Typical dose (adult) | Effect / target | Main use in MTP |
|---|---|---|---|
| Packed red cells (PRBC) | 1 unit raises Hb by ~1 g/dL (10 g/L) | Oxygen-carrying capacity; target Hb ~7–9 g/dL while bleeding | Backbone of every pack; emergency group O first |
| Fresh frozen plasma (FFP) | ~15 mL/kg (2 units in Pack 1, 6/subsequent pack) | All clotting factors; PT/APTT <1.5× normal | From the first pack; toward 1:1 with RBC |
| Platelets (SDP/apheresis or pooled RDP) | 1 adult dose ≈ ↑ 20–40 ×10⁹/L | Platelets >50 (>100 CNS/eye/ongoing) | In subsequent packs (6:6:6); >50 ×10⁹/L |
| Cryoprecipitate | ~2 pools (≈10 units) | Fibrinogen, VIII, XIII, vWF; fibrinogen >1.5 (–2 obstetric) g/L | When fibrinogen falls |
| Fibrinogen concentrate | 2–4 g | Rapid fibrinogen replacement (where available) | Alternative to cryoprecipitate |
| Whole blood (incl. LTOWB) | 1 unit ~450–500 mL | All components in one bag | Single-product initial resuscitation where stocked |
Tranexamic Acid · Calcium · Temperature · VHA
Do's & Don'ts
One clear call the moment major haemorrhage is actual or anticipated. Don't wait for the 10th unit.
Empirical until lab/VHA guide you (PROPPR: more early haemostasis).
1 g over 10 min then 1 g over 8 h (trauma); 1 g ± repeat (PPH).
Ionised Ca²⁺ >1.1–1.15 mmol/L; temperature >36 °C.
Surgery/IR/endoscopy/uterotonics; deactivate promptly when bleeding stops.
It dilutes clotting factors and worsens acidosis/hypothermia. Give components, not litres of saline.
Time-critical; given late in trauma it may increase mortality.
Transfuse empirically in a fixed ratio in the early phase.
The most commonly neglected steps — they perpetuate the bleeding.
Permissive hypotension until surgical control — but maintain perfusion in TBI.
Applying This in India (AIIMS / NBTC)
Adapt to what your blood bank actually stocks. District hospitals may not hold apheresis platelets (SDP) or fibrinogen concentrate and rely on whole blood, random-donor platelets (RDP) and cryoprecipitate — so agree local "pack" contents in advance with Transfusion Medicine. National guidance comes from the National Blood Transfusion Council (NBTC), with institutional protocols such as AIIMS New Delhi.
Tranexamic acid is a high-value, low-cost win every casualty, labour room and theatre can use early — the WOMAN trial ran largely in low- and middle-income settings including India. In obstetric haemorrhage (a leading cause of maternal death), combine early TXA with uterotonics, tamponade/balloon and a fibrinogen target >2 g/L.
Where resources are limited: activate early with one call; use fixed-ratio packs when VHA/lab turnaround is slow; never neglect calcium and warming (both nearly free); reserve O-negative for women of child-bearing potential; and run regular drills and audit — the biggest gains come from coordination, not exotic products.
References
- International Society of Blood Transfusion (ISBT), Clinical Transfusion Working Party. Patient Blood Management resources — Massive Bleeding Protocols. isbtweb.org (accessed July 2026).
- Holcomb JB, Tilley BC, Baraniuk S, et al. (PROPPR). Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs 1:1:2 Ratio and Mortality in Patients With Severe Trauma. JAMA. 2015;313:471–482.
- CRASH-2 Collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients. Lancet. 2010;376:23–32.
- WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality in post-partum haemorrhage. Lancet. 2017;389:2105–2116.
- Spahn DR, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma (6th edition). Crit Care. 2023;27:80.
- Hunt BJ, Allard S, Keeling D, et al. (BSH). A practical guideline for the haematological management of major haemorrhage. Br J Haematol. 2015;170:788–803.
- National Blood Transfusion Council (NBTC), India & institutional massive transfusion protocols (e.g. AIIMS New Delhi).
Educational summary of published guidance, written in the compiler's own words; always follow your own institution's approved massive transfusion protocol and blood-bank policies.